Clinical trial
Effects of ONO-2506PO in Patients With Alzheimer's Disease
NCT00083421 · Ono Pharma USA Inc, Industry · Completed
Key facts
| NCT number | NCT00083421 |
|---|---|
| Title | Effects of ONO-2506PO in Patients With Alzheimer's Disease |
| Official title | Effects of ONO-2506PO in Patients With Alzheimer's Disease |
| Lead sponsor | Ono Pharma USA Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | ONO-2506PO |
| Enrollment | 647 |
| Start date | Jun 1, 2004 |
| Completion | Jul 1, 2007 |
| First posted | Jun 18, 2004 |
| Last update posted | Jun 13, 2012 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: